Tumors can evade immune responses through suppressor signals that dysregulate host effector cell function. In this study we demonstrate that tumor-derived suppressor molecules impede host antitumor immune activity through dysregulation of multiple macrophage (MΦ) pathways, including suppressed production of cytotoxic and immunostimulatory agents and impaired expression of the interferon regulatory factor-8 (IRF-8) protein, a critical transducer of interferon-γ-mediated activation pathways. The tumor-derived immunosuppressive cytokines interieukin-10 and transforming growth factor-β, constrain IRF-8 production by normal MΦs, regardless of priming, and IRF-8 is also dysregulated in primary MΦs from tumorburdened hosts. Collectively, these data describe a new mechanism by which tumors disrupt immune function and suggest that abrogation of tumor-derived immunoregulatory factors in situ can restore immune function and enhance antitumor efficacy.
MicallefMJ, YoshidaK, KawaiS, HanayaT, KohnoK, AraiS, TanimotoT, TorigoeK, FujiiM, IkedaM, KurimotoM. In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites. Cancer Immunol Immunother43: 361–367, 1997.
2.
LopezDM, Handel-FernandezME, ChengX, CharyuluV, HerbertLM, DinapoliMR, CalderonCL. Cytokine production by lymphoreticular cells from mammary tumor bearing mice: The role of tumorderived factors. Anticancer Res16: 3923–3929, 1996.
3.
AllevaDG, BurgerCJ, ElgertKD. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-α production: Role of tumor-derived IL-10, TGF-β, and prostaglandin E2. J Immunol153: 1674–1686, 1994.
AhnH-J, MaruoS, TomuraM, MuJ, HamaokaT, NakanishiK, ClarkS, KurimotoM, OkamuraH, FujiwaraH. A mechanism underlying synergy between IL-12 and IFN-y-inducing factor in enhanced production of IFN-y. J Immunol159: 2125–2131, 1997.
7.
MullinsDW, WalkerTM, BurgerCJ, ElgertKD. Taxol-mediated changes in fibrosarcoma-induced immune cell function: Modulation of antitumor activities. Cancer Immunol Immunother45: 20–28, 1997.
8.
KaplanDH, ShankaranV, DigheAS, StockertE, AguetM, OldLJ, SchreiberRD. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA95: 7556–7561, 1998.
9.
MullinsDW, BurgerCJ, ElgertKD. Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide. J Immunol162: 6811–6818, 1999.
DinapoliMR, CalderonCL, LopezDM. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduced expression of the inducible nitric oxide synthase gene. J Exp Med183: 1323–1329, 1996.
12.
AllevaDG, BurgerCJ, ElgertKD. Tumor growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-γ. Scand J Immunol39: 31–38, 1994.
13.
MullinsDW, AllevaDG, BurgerCJ, ElgertKD. Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production. Immunopharmacology37: 63–73, 1997.
14.
AhmedSA, GogalRMJr., WalshJE. A new rapid and simple nonradioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assays. J Immunol Meth171: 211–224, 1994.
15.
MullinsDW, AskewD, ElgertKD. Tumor growth dysregulates macrophage production of bioactive interleukin-12. J Allergy Clin Immunol. 99: 449, 1997.
16.
WalkerTM, YurochkoAD, BurgerCJ, ElgertKD. Ia− macrophages and cytokine networks contribute to tumor-induced suppression of CD4+ autoreactive T cells. Immunol Invest22: 169–187, 1993.
17.
TrinchieriG. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol13: 251–276, 1995.
GorelikL, Bar-DaganY, MokyrMB. Insight into the mechanism(s) through which TNF promotes the generation of T cell-mediated antitumor cytotoxicity by tumor bearer splenic cells. J Immunol156: 4298–4308, 1996.
20.
CoxGW, MelilloG, ChattopadhyayU, MulletD, FertelRH, VaresioL. Tumor necrosis factor-α-dependent production of reactive nitrogen intermediates mediates IFN-γ plus IL-2-induced murine macrophage tumorcidal activity. J Immunol149: 3290–3296, 1992.
21.
MunderM, MalloM, EichmannK, ModolellM. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation. J Exp Med187: 2103–2108, 1998.
22.
ShibataY, FosterLA, KurimotoM, OkamuraH, NakamuraRM, KawajiriK, JusticeJP, Van ScottMR, MyrvikQN, MetzgerWJ. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-γ-inducing factors but enhances NK cell production of IFN-y. J Immunol161: 4289–4300, 1998.
23.
LiuW, KurlanderRJ. Analysis of the interrelationship between IL-12, TNF-alpha, and IFN-gamma production during murine listeriosis. Cell Immunol. 163: 260–267, 1995.
24.
BoehmU, KlampT, GrootM, HowardJC. Cellular responses to interferon-gamma. Annu Rev Immunol15: 749–795, 1997.
25.
Scharton-KerstenT, ContursiC, MasumiA, SherA, OzatoK. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction. J Exp Med186: 1523–1534, 1997.
26.
ContursiC, WangIM, GabrieleL, GadinaM, O'sheaJ, MorseHCIII, OzatoK. IFN consensus sequence binding protein potentiates STATI-dependent activation of IFNgamma-responsive promoters in macrophages. Proc Natl Acad Sci USA97: 91–96, 2000.
27.
GieseNA, GabrieleL, DohertyTM, KlinmanDM, Tadesse-HeathL, ContursiC, EpsteinSL, MorseHC. Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses In vivo through control of interleukin 12 expression. J Exp Med186: 1535–1546, 1997.
28.
KimYM, KangHS, PaikSG, PyunKH, AndersonKL, TorbettBE, ChoiI. Roles of IFN consensus sequence binding protein and PU.l in regulating IL-18 gene expression. J Immunol163: 2000–2007, 1999.
